WallStSmart
HCAT

Health Catalyst Inc

NASDAQ: HCAT · HEALTHCARE · HEALTH INFORMATION SERVICES

$1.34
-2.88% today

Updated 2026-06-02

Market cap
$142.62M
P/E ratio
P/S ratio
0.47x
EPS (TTM)
$-3.73
Dividend yield
52W range
$1 – $4
Volume
0.6M

Health Catalyst Inc (HCAT) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-57.20%
Operating margin
-11.60%
ROE
-192.01%
ROA
-3.48%
Debt/equity
0.14x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2017$73.08M$-47.03M40.28%-62.31%-64.36%
2018$112.57M$-61.98M46.83%-53.38%-55.06%
2019$154.94M$-60.10M51.37%-35.41%-38.79%
2020$188.84M$-115.02M48.06%-50.90%-60.91%
2021$241.93M$-153.21M48.60%-59.38%-63.33%
2022$276.24M$-137.40M48.21%-50.68%-49.74%
2023$295.94M$-118.15M44.55%-42.88%-39.92%
2024$306.58M$-69.50M45.92%-22.77%-22.67%
2025$311.14M$-177.97M33.47%-11.60%-57.20%

Frequently asked questions

What is Health Catalyst Inc's revenue?

Health Catalyst Inc's trailing twelve-month revenue is $302.48M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is HCAT?

In its most recent fiscal year, HCAT ran a gross margin of 33.47%, an operating margin of -11.60%, and a net margin of -57.20%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does HCAT generate?

HCAT produced $-237000.00 in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is HCAT's balance sheet healthy?

HCAT holds $50.81M in cash and equivalents against $151.62M in long-term debt, on $245.78M of shareholder equity. That debt is best read against the cash flow the business throws off each year.